Ranbaxy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 08, 2013, inter-alia, to consider and approve Standalone and Consolidated Unaudited Financial Results for the quarter ended March 31, 2013 (Q1) as reviewed by the Statutory Auditors of the Company.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
